Posts by: Iqra Mumal

Iqra Mumal

November 26, 2018November 26, 2018

Machine Deep Learning Shows Ability to Spot People Who Developed Alzheimer’s Years in Advance of Diagnosis

News

Deep learning, a type of artificial intelligence, used brain imaging scans to predict — years in advance and with nearly 100% sensitivity — patients who eventually developed Alzheimer’s disease, ... Read more

November 19, 2018November 19, 2018

Essential Oils Can Be Used as Potential Therapeutic for Alzheimer’s Disease, Study Suggests

News

Essential oils derived from different plant species have revealed encouraging clinical and preclinical results to reverse cognitive and memory impairments in Alzheimer’s disease, a review study has found. The ... Read more

October 12, 2018October 12, 2018

High Levels of Free Triiodothyronine Associated with Reduced Alzheimer’s Risk in Patients with Cognitive Impairment

News

High levels of free triiodothyronine — a type of thyroid hormone — are associated with a lower rate of Alzheimer’s disease risk in patients who have subjective or objective mild cognitive ... Read more

September 24, 2018September 24, 2018

New Strategy May Help Identify Those with Mild Cognitive Impairment at Risk to Develop Alzheimer’s

News

A newly developed strategy may help researchers identify which people with mild cognitive impairment are likely to develop Alzheimer’s disease. The study, “Utilizing Semantic Intrusions to Identify Amyloid Positivity in ... Read more

August 27, 2018August 27, 2018

ProMIS’ PMN310 Shows Improved Safety Profile, Specificity Compared to Similar Alzheimer’s Candidates

News

ProMIS Neurosciences’ lead therapeutic candidate for Alzheimer’s disease, PMN310, showed an improved safety profile when directly compared to other amyloid-beta directed antibodies, according to preclinical study results. Unlike BAN2401 (Biogen, Eisai) ... Read more

August 22, 2018August 22, 2018

Dysregulation of Iron Could Play a Central Role in Development of Early Onset Alzheimer’s

News

Iron dysregulation in the brains of patients with early onset of Alzheimer’s disease (EOfAD) plays a central role in disease development and progression, according to a new theory. The ... Read more

May 7, 2018May 7, 2018

New Genetically Engineered Rat Model Can Aid Alzheimer’s Research, Study Says

News

A rat model genetically engineered to express high levels of two genes can help researchers learn more about the disease mechanisms that lead to Alzheimer’s disease, a new study ... Read more

March 21, 2018March 21, 2018

Bryostatin Improves Cognition in Patients with Advanced Alzheimer’s, Analysis Finds

News

Bryostatin, Neurotrope Bioscience’s investigational therapy, was associated with improved cognition in advanced Alzheimer’s disease patients in post-hoc (after-the-fact) analysis of a Phase 2 trial. Results from this study were presented ... Read more

January 31, 2018

Poor Results Prompt Takeda and Zinfandel to End Phase 3 Alzheimer’s Therapy Trial Early

News

Takeda Pharmaceutical Company and Zinfandel Pharmaceuticals have brought an early end to a Phase 3 clinical trial after their Alzheimer’s therapy pioglitazone failed to prevent the development of mild cognitive impairment. The ... Read more

January 8, 2018January 8, 2018

Diabetes Therapy Could Be Used to Treat Alzheimer’s, Study Reports

News

An approved treatment for diabetes may help people with Alzheimer’s, a study reports. The research, “Neuroprotective effects of a triple GLP-1/GIP/glucagon receptor agonist in the APP/PS1 transgenic mouse model ... Read more

Pin It on Pinterest